NO20060607L - Ny fremgangsmate - Google Patents

Ny fremgangsmate

Info

Publication number
NO20060607L
NO20060607L NO20060607A NO20060607A NO20060607L NO 20060607 L NO20060607 L NO 20060607L NO 20060607 A NO20060607 A NO 20060607A NO 20060607 A NO20060607 A NO 20060607A NO 20060607 L NO20060607 L NO 20060607L
Authority
NO
Norway
Prior art keywords
new procedure
producing
high yield
new process
small crystal
Prior art date
Application number
NO20060607A
Other languages
English (en)
Inventor
Philippe Rogueda
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20060607L publication Critical patent/NO20060607L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • B01D9/0054—Use of anti-solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0063—Control or regulation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/0081—Use of vibrations, e.g. ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Abstract

Det beskrives en ny fremgangsmåte for fremstilling av et høyt utbytte av partikler med liten krystallstørrelse og snever størrelsesfordeling.
NO20060607A 2003-07-07 2006-02-07 Ny fremgangsmate NO20060607L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302029A SE0302029D0 (sv) 2003-07-07 2003-07-07 Novel process
PCT/GB2004/002882 WO2005004847A1 (en) 2003-07-07 2004-07-05 Novel process

Publications (1)

Publication Number Publication Date
NO20060607L true NO20060607L (no) 2006-04-07

Family

ID=27764955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060607A NO20060607L (no) 2003-07-07 2006-02-07 Ny fremgangsmate

Country Status (14)

Country Link
US (1) US20060188579A1 (no)
EP (1) EP1648414A1 (no)
JP (1) JP2007527381A (no)
KR (1) KR20060052779A (no)
CN (1) CN1819818A (no)
AU (1) AU2004255517A1 (no)
BR (1) BRPI0412445A (no)
CA (1) CA2531025A1 (no)
IL (1) IL172771A0 (no)
MX (1) MXPA05014075A (no)
NO (1) NO20060607L (no)
SE (1) SE0302029D0 (no)
WO (1) WO2005004847A1 (no)
ZA (1) ZA200600110B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
PL1921919T3 (pl) * 2005-07-14 2012-09-28 Lithera Inc Ulepszona lipolityczna formulacja o podtrzymywanym uwalnianiu do traktowania lokalnej tkanki tłuszczowej
MX2009004198A (es) * 2006-10-17 2009-10-19 Lithera Inc Metodos, composiciones y formulaciones para el tratamiento de enfermedad ocular tiroidea.
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
EP3090792A1 (en) * 2008-07-18 2016-11-09 Prosonix Limited Process for improving crystallinity
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
CN102869363A (zh) * 2010-01-15 2013-01-09 利赛拉公司 冻干的块状制剂
EP2618818A4 (en) * 2010-09-22 2014-10-29 Map Pharmaceuticals Inc CORTICOSTEROID PARTICLES AND METHOD FOR PRODUCING THE SAME
GEP201606551B (en) 2010-11-24 2016-10-10 Novamedica Llc Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
JP6092121B2 (ja) * 2011-01-09 2017-03-08 エイエヌピー テクノロジーズ， インコーポレイテッド 疎水性分子に誘起された分岐ポリマー凝集体及びその使用
CN102807585B (zh) * 2012-08-06 2015-08-12 广西田园生化股份有限公司 一种采用超声波辅助技术结晶毒氟磷的方法
CN103588846B (zh) * 2012-08-15 2016-08-03 重庆华邦制药有限公司 一种丙酸氟替卡松微粒的制备方法及其用途
WO2014137982A1 (en) 2013-03-08 2014-09-12 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution
CN109988074A (zh) * 2018-06-01 2019-07-09 药璞(上海)医药科技有限公司 一种适合药用的硫酸特布他林晶型b的制备方法
WO2022134000A1 (zh) * 2020-12-25 2022-06-30 深圳晶泰科技有限公司 连续激发结晶的方法及系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
ES2261730T3 (es) * 2001-05-05 2006-11-16 Accentus Plc Formacion de cristales pequeños.
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
JP5172075B2 (ja) * 2002-10-17 2013-03-27 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 吸入可能な薬物の粉末を製造するための方法及びリアクター

Also Published As

Publication number Publication date
WO2005004847A1 (en) 2005-01-20
KR20060052779A (ko) 2006-05-19
IL172771A0 (en) 2006-04-10
US20060188579A1 (en) 2006-08-24
CA2531025A1 (en) 2005-01-20
MXPA05014075A (es) 2006-03-02
CN1819818A (zh) 2006-08-16
ZA200600110B (en) 2007-01-31
JP2007527381A (ja) 2007-09-27
AU2004255517A1 (en) 2005-01-20
EP1648414A1 (en) 2006-04-26
SE0302029D0 (sv) 2003-07-07
BRPI0412445A (pt) 2006-09-19

Similar Documents

Publication Publication Date Title
NO20060607L (no) Ny fremgangsmate
NO20052244D0 (no) Enantioselektiv fremgangsmate for fremstilling av begge enantiomerene av 10,11- dihydro-10-hydroksy-5H-dibenzo[b,f]- azepin-5-karboksamid og nye krystallformer derav
NO20051393L (no) Prosess og intermediater for fremstilling av tienopyrrol-derivater
NO20024808D0 (no) Fremgangsmåte ved syntesen av perindopril og farmasöytisk akseptable salter derav
AU2003268522A1 (en) Apparatus and process for production of high purity hydrogen
NO20034366L (no) Apparatur og produksjonsmetode for produksjon av hydrogen med höyt trykk
TW200512191A (en) Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
NO20024319D0 (no) Fremgangsmåte og anordning for syretilsetning av hydrokarbonkilder
AU2003211162A1 (en) High frequency semiconductor device and method of manufacture
SG158090A1 (en) New process for large-scale production of monodisperse nanoparticles
DE60324949D1 (de) Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
AU2003270022A1 (en) Method and apparatus for the manufacture of high temperature materials by combustion synthesis and semi-solid forming
NO20083269L (no) Prosess for a anvende krystallinsk orlistatmetoder
EP1574602A4 (en) METHOD FOR MAKING COMPOUND SEMICONDUCTOR MONOCRYSTAL AND ASSOCIATED CRYSTAL DRAINING APPARATUS
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MY139159A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
GEP20074257B (en) Novel method for the synthesis of s-indoline-2-carboxylic acid and application thereof in the synthesis of perindopril
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
NO20060922L (no) Ny fremgangsmate for syntesen av perindopril og dens farmasoytiske akseptable salter
AU2003220910A1 (en) Process for production of fullerenes and method for separation thereof
MY143244A (en) Calcilytic compounds
AU2003302328A8 (en) Crystal structure of glutamate racemase (muri)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application